Spyglass Capital Management LLC Exact Sciences Corp Transaction History

Spyglass Capital Management LLC

  • $1.48 Billion
  • Q3 2024

A detailed history of Spyglass Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Spyglass Capital Management LLC holds 1,397,093 shares of EXAS stock, worth $78.4 Million. This represents 6.41% of its overall portfolio holdings.

Number of Shares
1,397,093
Previous 1,418,591 1.52%
Holding current value
$78.4 Million
Previous $59.9 Million 58.72%
% of portfolio
6.41%
Previous 4.39%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$42.43 - $70.83 $912,160 - $1.52 Million
-21,498 Reduced 1.52%
1,397,093 $95.1 Million
Q2 2024

Aug 14, 2024
BUY
$41.33 - $74.26 $14.8 Million - $26.6 Million
357,943 Added 33.75%
1,418,591 $59.9 Million
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $17 Million - $22.3 Million
302,050 Added 39.82%
1,060,648 $73.2 Million
Q4 2023

Feb 14, 2024
BUY
$59.06 - $75.72 $12.4 Million - $15.8 Million
209,173 Added 38.07%
758,598 $56.1 Million
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $7.42 Million - $11.1 Million
-112,505 Reduced 17.0%
549,425 $37.5 Million
Q2 2023

Aug 14, 2023
SELL
$62.68 - $95.05 $23.8 Million - $36.1 Million
-379,516 Reduced 36.44%
661,930 $62.2 Million
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $10.7 Million - $16.1 Million
-227,757 Reduced 17.94%
1,041,446 $70.6 Million
Q4 2022

Feb 14, 2023
SELL
$30.35 - $53.15 $18.4 Million - $32.1 Million
-604,665 Reduced 32.27%
1,269,203 $62.8 Million
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $10.1 Million - $15.6 Million
-315,142 Reduced 14.4%
1,873,868 $60.9 Million
Q2 2022

Aug 15, 2022
SELL
$35.61 - $76.23 $6.8 Million - $14.6 Million
-190,943 Reduced 8.02%
2,189,010 $86.2 Million
Q1 2022

May 16, 2022
SELL
$57.56 - $82.54 $16.7 Million - $23.9 Million
-289,763 Reduced 10.85%
2,379,953 $166 Million
Q4 2021

Feb 14, 2022
BUY
$72.5 - $100.68 $30 Million - $41.7 Million
413,713 Added 18.34%
2,669,716 $208 Million
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $54.5 Million - $74.9 Million
604,182 Added 36.58%
2,256,003 $215 Million
Q2 2021

Aug 16, 2021
BUY
$93.66 - $139.27 $10.2 Million - $15.1 Million
108,666 Added 7.04%
1,651,821 $205 Million
Q1 2021

May 17, 2021
BUY
$116.57 - $155.01 $23.7 Million - $31.6 Million
203,632 Added 15.2%
1,543,155 $203 Million
Q4 2020

Feb 16, 2021
BUY
$99.61 - $142.12 $21.1 Million - $30.2 Million
212,168 Added 18.82%
1,339,523 $177 Million
Q3 2020

Nov 16, 2020
BUY
$72.92 - $102.01 $14.3 Million - $20 Million
196,351 Added 21.09%
1,127,355 $115 Million
Q2 2020

Aug 14, 2020
BUY
$55.75 - $92.75 $11.6 Million - $19.3 Million
208,133 Added 28.79%
931,004 $80.9 Million
Q1 2020

May 15, 2020
BUY
$37.9 - $104.44 $12.7 Million - $35.1 Million
335,754 Added 86.73%
722,871 $41.9 Million
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $20.2 Million - $26 Million
260,397 Added 205.49%
387,117 $35.8 Million
Q3 2019

Nov 14, 2019
BUY
$90.37 - $122.49 $4.93 Million - $6.68 Million
54,567 Added 75.63%
126,720 $11.5 Million
Q2 2019

Aug 14, 2019
BUY
$89.51 - $118.04 $1.2 Million - $1.58 Million
13,351 Added 22.71%
72,153 $8.52 Million
Q1 2019

May 15, 2019
SELL
$61.98 - $96.5 $1.9 Million - $2.96 Million
-30,718 Reduced 34.31%
58,802 $5.09 Million
Q4 2018

Feb 14, 2019
BUY
$56.04 - $82.66 $5.02 Million - $7.4 Million
89,520 New
89,520 $5.65 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.93B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Spyglass Capital Management LLC Portfolio

Follow Spyglass Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spyglass Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spyglass Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email